Recent Posts

1. 

   Bring Anthony Mancini back as CEO

   Looking at the sales of Sotyktu & Abecma. Lurch & Hoch must bone each other till either tap out. It would be less than 2 minutes. Hoch has a bigger penia.

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 1:42 PM

2. 

   Region collapsing

   so disappointing to hear this. i left a SC role this year for greener pastures and my old team is in total chaos and revolt. jnj is a far cray from the good old days of synthes

   Synthes

   anonymous

   Apr 25, 2024 at 1:38 PM

3. 

   NYS.....

   PSA: Replying All to an email that 100 people are copied on is only not annoying to the person it’s about. Everyone else hates you for it. Please stop, trust me I’m doing you a favor.

   Novo Nordisk

   anonymous

   Apr 25, 2024 at 1:38 PM

4. 

   Elevar

   Meh? Go fuck yourself

   Biotech Startups

   anonymous

   Apr 25, 2024 at 1:33 PM

5. 

   It's the first drug shown to slow Alzheimer's. Why is it off to a slow start? | AP News

   Dumbass ABLs leading the charge

   Eisai

   anonymous

   Apr 25, 2024 at 1:26 PM

6. 

   Sell Otezla and Keep Sotyktu?

   18 months in and we are selling $34millon in the U.S. for the quarter. Otezla has been selling $170million every MONTH since we sold it off in favor of Sotyktu. We are so far behind on the P&L that we now need to ramp up peak years sales to...

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 1:23 PM

7. 

   How to destroy field medical

   Listen honey, we gotta get out there and hustle! This ain't no desk job. We gotta be with the folks we're helping, face-to-face. That's how you get things done, you understand? You gotta put in the miles to make a difference If this ain't your...

   Genentech

   anonymous

   Apr 25, 2024 at 1:21 PM

8. + Show More